Rakovina therapeutics showcases preclinical results of novel ai-discovered cancer therapies at aacr 2025

Data highlights novel parp1 and atr inhibitors with progress toward next-generation therapies for hard-to-treat malignancies data highlights novel parp1 and atr inhibitors with progress toward next-generation therapies for hard-to-treat malignancies
ATR Ratings Summary
ATR Quant Ranking